A 72-year-old man presented to our hospital with a onemonth history of chest pain and dyspnea.
phosphamide, vincristine, prednisolone (THP-COP) therapy was commenced (1) . A contrast-enhanced CT scan performed after two cycles of treatment subsequently showed marked tumor regression (Picture 4); therefore, the patient was discharged from the hospital.
Cardiac malignant lymphoma is extremely rare, accounting for only 1.3% of cardiac tumors (2), and there is no consensus as to treatment. In the current case, the patient underwent an additional four cycles of therapy at another hospital after being discharged from our hospital; however, he ultimately died of gastric cancer.
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